Latest U.S. Food and Drug Administration Stories
WASHINGTON, Nov. 25, 2014 /PRNewswire-USNewswire/ -- Trust for America's Health (TFAH) applauds the U.S.
Dr. Daniel M. Takefman brings 15 years of FDA experience to leading gene therapy company PHILADELPHIA, Nov.
-Expects to be eligible for 180 days of marketing exclusivity- PITTSBURGH, Nov. 25, 2014 /PRNewswire/ -- Mylan Inc.
WHIPPANY, N.J., Nov. 24, 2014 /PRNewswire/ -- The U.S.
BUENA, N.J., Nov. 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
SILVER SPRING, Md., Nov. 20, 2014 /PRNewswire-USNewswire/ -- The winter of 2014 - 2015 has arrived early this year.
HAMPTON, N.J. and HONG KONG, Nov. 19, 2014 /PRNewswire/ -- Ikaria, Inc.
WASHINGTON, Nov. 18, 2014 /PRNewswire-USNewswire/ -- The U.S.
Company plans to commence clinical development of SUBA®-Itraconazole for treatment of basal cell carcinoma in patients with basal cell carcinoma nevus syndrome TAMPA, Fla.
ROCKVILLE, Md., Nov. 17, 2014 /PRNewswire/ -- TissueGene, Inc., a clinical stage biopharmaceutical company, has received recommendations from the U.S.
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.